Please log in to see the full text of this API!
Erdafitinib
-
Synonyms:
JNJ-42756493; JNJ-493; G-024
-
ATC:
L01EX16
-
Use:
Lorem
-
Chemical name:
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:446.6 g/mol
-
CAS-RN:1346242-81-6
-
InChI Key:OLAHOMJCDNXHFI-UHFFFAOYSA-N
-
InChI:InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3
Synthesis Path
Substances Referenced in Synthesis Path
CAS-RN |
Formula |
Chemical Name |
CAS Index Name |
82031-32-1 |
C8H5BrN2O |
7-bromo-2(1H)-quinoxazolinone |
|
761446-44-0 |
C10H17BN2O2 |
1-methyl-4-(4,4,5,5-tetramethyl- 1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
|
1083325-87-4 |
C12H9BrN4 |
7-bromo-2-(1-methyl-1H-pyrazol-4-yl)quinoxazoline |
|
75-31-0 |
C3H9N |
isopropylamine |
|
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Trade Names
Country |
Trade Name |
Vendor |
Annotation |
USA |
Lorem |
Lorem
|
|
(wfm = withdrawn from market)
Formulations
- Loremipsumdolorsitamet,consetetur
References
-
- Perera, T.P.S. et al., Molecular Cancer Therap., (2017) 16/6, 1010-1020.
- WO 9999 999999 (Astex Therap.; 3.11.2011; appl. 28.4.2011; USA-prior. 30.4.2010).
- US 9 999 999 (Astex Therap.; 25.11.2014; appl. 28.11.2011; USA-prior. 30.4.2010).
- US 9 999 999 (Astex Therap.; 11.10.2016; appl. 2.10.2014; GB-prior. 30.4.2010).
-
Combinations:
- US 9999 9999999 (Astex Therap.; 13.4.2017; appl. 26.3.2015; EP-prior. 26.3.2014).